Cargando…
Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells
Constitutive expression of active Akt (Akt(tg)) drives hyperplasia and hypertrophy of pancreatic β-cells, concomitantly with increased insulin secretion and improved glucose tolerance, and at a later stage the development of insulinoma. To determine which functions of Akt are mediated by ribosomal p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769037/ https://www.ncbi.nlm.nih.gov/pubmed/26919188 http://dx.doi.org/10.1371/journal.pone.0149995 |
_version_ | 1782418041656573952 |
---|---|
author | Wittenberg, Avigail Dreazen Azar, Shahar Klochendler, Agnes Stolovich-Rain, Miri Avraham, Shlomit Birnbaum, Lea Binder Gallimidi, Adi Katz, Maximiliano Dor, Yuval Meyuhas, Oded |
author_facet | Wittenberg, Avigail Dreazen Azar, Shahar Klochendler, Agnes Stolovich-Rain, Miri Avraham, Shlomit Birnbaum, Lea Binder Gallimidi, Adi Katz, Maximiliano Dor, Yuval Meyuhas, Oded |
author_sort | Wittenberg, Avigail Dreazen |
collection | PubMed |
description | Constitutive expression of active Akt (Akt(tg)) drives hyperplasia and hypertrophy of pancreatic β-cells, concomitantly with increased insulin secretion and improved glucose tolerance, and at a later stage the development of insulinoma. To determine which functions of Akt are mediated by ribosomal protein S6 (rpS6), an Akt effector, we generated mice that express constitutive Akt in β-cells in the background of unphosphorylatable ribosomal protein S6 (rpS6(P-/-)). rpS6 phosphorylation deficiency failed to block Akt(tg)-induced hypertrophy and aneuploidy in β-cells, as well as the improved glucose homeostasis, indicating that Akt carries out these functions independently of rpS6 phosphorylation. In contrast, rpS6 phosphorylation deficiency efficiently restrained the reduction in nuclear localization of the cell cycle inhibitor p27, as well as the development of Akt(tg)-driven hyperplasia and tumor formation in β-cells. In vitro experiments with Akt(tg) and rpS6(P-/-);Akt(tg) fibroblasts demonstrated that rpS6 phosphorylation deficiency leads to reduced translation fidelity, which might underlie its anti-tumorigenic effect in the pancreas. However, the role of translation infidelity in tumor suppression cannot simply be inferred from this heterologous experimental model, as rpS6 phosphorylation deficiency unexpectedly elevated the resistance of Akt(tg) fibroblasts to proteotoxic, genotoxic as well as autophagic stresses. In contrast, rpS6(P-/-) fibroblasts exhibited a higher sensitivity to these stresses upon constitutive expression of oncogenic Kras. The latter result provides a possible mechanistic explanation for the ability of rpS6 phosphorylation deficiency to enhance DNA damage and protect mice from Kras-induced neoplastic transformation in the exocrine pancreas. We propose that Akt1 and Kras exert their oncogenic properties through distinct mechanisms, even though both show addiction to rpS6 phosphorylation. |
format | Online Article Text |
id | pubmed-4769037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47690372016-03-09 Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells Wittenberg, Avigail Dreazen Azar, Shahar Klochendler, Agnes Stolovich-Rain, Miri Avraham, Shlomit Birnbaum, Lea Binder Gallimidi, Adi Katz, Maximiliano Dor, Yuval Meyuhas, Oded PLoS One Research Article Constitutive expression of active Akt (Akt(tg)) drives hyperplasia and hypertrophy of pancreatic β-cells, concomitantly with increased insulin secretion and improved glucose tolerance, and at a later stage the development of insulinoma. To determine which functions of Akt are mediated by ribosomal protein S6 (rpS6), an Akt effector, we generated mice that express constitutive Akt in β-cells in the background of unphosphorylatable ribosomal protein S6 (rpS6(P-/-)). rpS6 phosphorylation deficiency failed to block Akt(tg)-induced hypertrophy and aneuploidy in β-cells, as well as the improved glucose homeostasis, indicating that Akt carries out these functions independently of rpS6 phosphorylation. In contrast, rpS6 phosphorylation deficiency efficiently restrained the reduction in nuclear localization of the cell cycle inhibitor p27, as well as the development of Akt(tg)-driven hyperplasia and tumor formation in β-cells. In vitro experiments with Akt(tg) and rpS6(P-/-);Akt(tg) fibroblasts demonstrated that rpS6 phosphorylation deficiency leads to reduced translation fidelity, which might underlie its anti-tumorigenic effect in the pancreas. However, the role of translation infidelity in tumor suppression cannot simply be inferred from this heterologous experimental model, as rpS6 phosphorylation deficiency unexpectedly elevated the resistance of Akt(tg) fibroblasts to proteotoxic, genotoxic as well as autophagic stresses. In contrast, rpS6(P-/-) fibroblasts exhibited a higher sensitivity to these stresses upon constitutive expression of oncogenic Kras. The latter result provides a possible mechanistic explanation for the ability of rpS6 phosphorylation deficiency to enhance DNA damage and protect mice from Kras-induced neoplastic transformation in the exocrine pancreas. We propose that Akt1 and Kras exert their oncogenic properties through distinct mechanisms, even though both show addiction to rpS6 phosphorylation. Public Library of Science 2016-02-26 /pmc/articles/PMC4769037/ /pubmed/26919188 http://dx.doi.org/10.1371/journal.pone.0149995 Text en © 2016 Wittenberg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Wittenberg, Avigail Dreazen Azar, Shahar Klochendler, Agnes Stolovich-Rain, Miri Avraham, Shlomit Birnbaum, Lea Binder Gallimidi, Adi Katz, Maximiliano Dor, Yuval Meyuhas, Oded Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title_full | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title_fullStr | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title_full_unstemmed | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title_short | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
title_sort | phosphorylated ribosomal protein s6 is required for akt-driven hyperplasia and malignant transformation, but not for hypertrophy, aneuploidy and hyperfunction of pancreatic β-cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769037/ https://www.ncbi.nlm.nih.gov/pubmed/26919188 http://dx.doi.org/10.1371/journal.pone.0149995 |
work_keys_str_mv | AT wittenbergavigaildreazen phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT azarshahar phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT klochendleragnes phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT stolovichrainmiri phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT avrahamshlomit phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT birnbaumlea phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT bindergallimidiadi phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT katzmaximiliano phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT doryuval phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells AT meyuhasoded phosphorylatedribosomalproteins6isrequiredforaktdrivenhyperplasiaandmalignanttransformationbutnotforhypertrophyaneuploidyandhyperfunctionofpancreaticbcells |